The Stock Of The Week: DURECT Corporation (DRRX)

As of Wednesday close, DURECT Corporation’s (NASDAQ:DRRX) stock was up $0.08, moving up 16.48 percent to $0.53. The average number of shares traded per day over the past five days has been 1,176,520 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.0413 fall in that time frame. In the last twenty days, the average volume was 1,065,480, while in the previous 50 days, it was 1,020,952.

Since last month, DRRX stock rose 32.80%. Shares of the company fell to $0.3601 on 05/24/22, the lowest level in the past month. A 52-week high of $1.84 was reached on 01/03/22 after having rallying from a 52-week low of $0.36. Since the beginning of this year, DRRX’s stock price has dropped by -46.58% or -$0.4592, and marked a new high 1 time. However, the stock has declined by -71.37% since its 52-week high.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


DURECT Corporation (DRRX) last reported insider trading activity 28 days ago on May 26. Robertson Judith J., the Director of the company, purchased of 65,000 shares for $0.39 on May 26. It resulted in a $25,597 investment by the insider. AZAB MOHAMMAD added 30,000 shares at an average price of $0.39 on May 24. The insider now owns 60,000 shares following the transaction. On May 18, Director Farfel Gail M bought 29,911 shares at $0.41 apiece. The transaction was valued at $12,201.

Valuation Metrics

The stock’s beta is 1.38. Besides these, the trailing price-to-sales (P/S) ratio of 8.98, the price-to-book (PB) ratio of 2.51.

Financial Health

In the three months ended March 30, DURECT Corporation’s quick ratio stood at 7.60, while its current ratio was 7.80, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending March 30 was 0.44. On the profitability front, the trailing twelve-month gross margin is 85.80% percent. Based on annual data, DRRX earned $12.02 million in gross profit and brought in $13.98 million in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -43.70%. Return on equity (ROE) for the past 12 months was -60.90%.

In DURECT Corporation’s quarter-end financial report for March 30, it reported total debt of $20.77 million against cash and short-term investments of $14.76 million. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. DRRX’s revenue fell -15.1% to $7.3 million during the quarter, while net income inched up to $1.92 million. While analysts expected DURECT Corporation to report -$0.05 quarterly earnings, the actual figure was -$0.05 per share. During the quarter, the company generated -$10.21 million in EBITDA. The liabilities of DURECT Corporation were 32.92 million at the end of its most recent quarter ended March 30, and its total debt was $24.3 million. The value of shareholders’ equity is $227.76 million.

Technical Picture

This quick technical analysis looks at DURECT Corporation’s (DRRX) price momentum. With a historical volatility rate of 128.97%, the RSI 9-day stood at 52.16% on 22 June.

With respect to its five-day moving average, the current DURECT Corporation price is down by -7.27% percent or -$0.0413. At present, DRRX shares trade +35.05% above its 20-day simple moving average and -20.74% percent below its 100-day simple moving average. However, the stock is currently trading approximately -2.46% below its SMA50 and -61.27% below its SMA200.

Stochastic coefficient K was 26.98% and Stochastic coefficient D was 30.05%, while ATR was 0.0770. Given the Stochastic reading of 42.81% for the 14-day period, the RSI (14) reading has been calculated as 52.62%. As of today, the MACD Oscillator reading stands at -0.0573, while the 14-day reading stands at -0.0458.

Analyst Ratings

Chardan Capital Markets launched its rating on DURECT Corporation (NASDAQ: DRRX) to a Buy in a note to investors on October 30, 2020. DURECT Corporation (DRRX) has been rated Buy by analysts. According to 0 brokerage firms, DRRX is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate DURECT Corporation stock as buy, with 3 recommending it as overweight.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam